Outlook Therapeutics, Inc. (OTLK)
USD 1.4
(-2.78%)
USD 1.4
(-2.78%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -42.97 Million | -56.67 Million | -54.25 Million | -31.79 Million | -32.28 Million | -33.03 Million |
| Net Income | -58.98 Million | -66.05 Million | -53.16 Million | -35.23 Million | -34.52 Million | -46.11 Million |
| Depreciation & Amortization | 44.18 Thousand | 204.69 Thousand | 262.14 Thousand | 554.06 Thousand | 3.36 Million | -3.05 Million |
| Deferred income taxes | 537.73 Thousand | - | 498.48 Thousand | 2.23 Million | 9.43 Million | 20.14 Million |
| Stock-based compensation | 5.54 Million | 7.71 Million | 4.88 Million | 2.8 Million | 1.31 Million | 1.98 Million |
| Change in working capital | 4.75 Million | -1.68 Million | -7.07 Million | -1.26 Million | -13.19 Million | -13.68 Million |
| Other non-cash items | 5.12 Million | 3.14 Million | 341.54 Thousand | -881.32 Thousand | 1.31 Million | 7.68 Million |
| Investing Cash Flow | - | - | - | -900 Thousand | -437.3 Thousand | -2.78 Million |
| Investments in PPE | -2.00 | - | - | - | -437.3 Thousand | -2.78 Million |
| Acquisitions | - | - | - | -900 Thousand | - | - |
| Investment purchases | - | - | - | -900 Thousand | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | 900 Thousand | - | - |
| Financing Cash Flow | 48.96 Million | 59.59 Million | 56.19 Million | 37.21 Million | 39.02 Million | 34.35 Million |
| Debt repayment | -10.23 Million | -12.31 Million | -3.69 Million | -263.27 Thousand | -6.94 Million | -990.64 Thousand |
| Dividends payments | - | - | - | - | - | -1886.94 Billion |
| Common Stock Repurchased | - | - | - | 166.13 Billion | 624.98 Billion | -1.08 Million |
| Common Stock Issuance | 30.02 Million | 62.3 Million | 46.3 Million | 35.43 Million | 45.96 Million | 36.43 Million |
| Other Financing Activities | 29.17 Million | 9.6 Million | 13.58 Million | 2.04 Million | 4350.00 | 1.08 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 3.08 Million | 1.29 Million | -198.46 Thousand | -1.48 Million | -1.33 Million | -6.71 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.67 Million | -2.97 Million | -6.88 Million | 220.03 Thousand | -11.86 Million | -6.96 Million |
| Cash at beginning of period | 17.39 Million | 14.47 Million | 12.53 Million | 8.01 Million | 1.71 Million | 3.18 Million |
| Cash at end of period | 23.39 Million | 17.39 Million | 14.47 Million | 12.53 Million | 8.01 Million | 1.71 Million |
| Capital Expenditure | -2.00 | - | - | - | -437.3 Thousand | -2.78 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 5.99 Million | 2.91 Million | 1.94 Million | 4.52 Million | 6.29 Million | -1.46 Million |
| Free Cash Flow | -42.97 Million | -56.67 Million | -54.25 Million | -31.79 Million | -32.72 Million | -35.82 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 44.4 Million | -114.28 Million | -11.17 Million | -12.99 Million | -58.98 Million | -20.67 Million |
| Depreciation & Amortization | 28.67 Thousand | 28.19 Thousand | 28.19 Thousand | 11.21 Thousand | 44.18 Thousand | 11.19 Thousand |
| Deferred income taxes | - | - | 50.79 Thousand | -18.93 Thousand | 537.73 Thousand | 18.93 Thousand |
| Stock-based compensation | 1.39 Million | 1.31 Million | 1.27 Million | 1.38 Million | 5.54 Million | 1.38 Million |
| Change in working capital | -1.77 Million | -1.26 Million | -4.19 Million | -1.98 Million | 4.75 Million | 3.13 Million |
| Other non-cash items | -63.8 Million | 96.04 Million | 993 Thousand | 856.49 Thousand | 5.12 Million | 2.91 Million |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | -3.00 | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 4.3 Million | 56.13 Million | -3183.00 | 2.42 Million | 48.96 Million | 3.29 Million |
| Debt repayment | - | -1084.00 | -3183.00 | -3082.00 | -10.23 Million | -2983.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 4.3 Million | 56.14 Million | - | 2.42 Million | 30.02 Million | 3.29 Million |
| Other Financing Activities | 4307.64 | 56.14 Thousand | - | 2424.22 | 29.17 Million | 3296.19 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 1.69 Million | 267 Thousand | -3.09 Million | 1.75 Million | 3.08 Million | 1.19 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -3.46 Million | -1.52 Million | -1.1 Million | -3.74 Million | 1.67 Million | 1.94 Million |
| Cash at beginning of period | 47.22 Million | 10.35 Million | 23.39 Million | 33.7 Million | 17.39 Million | 43.62 Million |
| Cash at end of period | 32.02 Million | 47.22 Million | 10.35 Million | 23.39 Million | 23.39 Million | 33.7 Million |
| Capital Expenditure | -3.00 | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -15.2 Million | 36.87 Million | -13.03 Million | -10.31 Million | 5.99 Million | -9.92 Million |
| Free Cash Flow | -19.51 Million | -19.26 Million | -13.03 Million | -12.74 Million | -42.97 Million | -13.21 Million |
KIRLPNU
1737
9627
XNCR
BALKRISIND
PADI